-Kazutsugu Uematsu Researcher Activity Profile

Research Author Detailed Information 

Kazutsugu Uematsu Publication Rate By Year

Kazutsugu Uematsu has published 3 paper(s) in 2004, 1 paper(s) in 2005, 7 paper(s) in 2007, 2 paper(s) in 2008, for a total of 13 research publications in total.

Kazutsugu K Uematsu Author Information

LAST NAME: uematsu

FIRST NAME: kazutsugu

INITIALS: K

AFFILIATION:

Papers

Kazutsugu Uematsu's Publication Record

1. Easier understanding of pleural indentation on computed tomography. Year Published: 2007
Division of Medical Oncology, Tokai University School of Medicine, Isehara. seki@is.icc.u-tokai.ac.jp
2. Irreversible Imatinib-induced Pneumonitis following Long-term Imatinib Administration. Year Published: 2007
Division of Medical Oncology, Tokai University School of Medicine.
3. Irreversible imatinib-induced pneumonitis following long-term imatinib administration. Year Published: 2007
Division of Medical Oncology, Tokai University School of Medicine, Isehara. seki@is.icc.u-tokai.ac.jp
4. Easier understanding of pleural indentation on computed tomography. Year Published: 2007
Division of Medical Oncology, Tokai University School of Medicine.
5. Irreversible imatinib-induced pneumonitis following long-term imatinib administration. Year Published: 2007
Division of Medical Oncology, Tokai University School of Medicine, Isehara. seki@is.icc.u-tokai.ac.jp
6. Inhibition of Wnt-1 signaling induces apoptosis in beta-catenin-deficient mesothelioma cells. Year Published: 2004
Thoracic Oncology Laboratory, Department of Surgery, Comprehensive Cancer Center, University of California, San Francisco, California 94115, USA.
7. An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth. Year Published: 2004
Thoracic Oncology Laboratory, Department of Surgery, Comprehensive Cancer Center, University of California-San Francisco, 1600 Divisadero Street, San Francisco, CA 94143-1674, USA.
8. Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells. Year Published: 2004
Thoracic Oncology Laboratory, Department of Surgery, Comprehensive Cancer Center, University of California, San Francisco, CA 94115, USA.
9. Efficacy of Wnt-1 monoclonal antibody in sarcoma cells. Year Published: 2005
Department of Surgery, Comprehensive Cancer Center, University of California, San Francisco, CA 94115, USA. imikami@cc.ucsf.edu
10. An antagonist of dishevelled protein-protein interaction suppresses beta-catenin-dependent tumor cell growth. Year Published: 2007
Department of Pharmaceutical Chemistry, Thoracic Oncology Labratory, University of California San Francisco, and Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Naoaki.Fujii@stjude.org
11. Easier understanding of pleural indentation on computed tomography. Year Published: 2007
Division of Medical Oncology, Tokai University School of Medicine, Isehara. seki@is.icc.u-tokai.ac.jp
12. Targeting the Wnt signaling pathway with dishevelled and cisplatin synergistically suppresses mesothelioma cell growth. Year Published: 2008
Division of Clinical Oncology, Tokai University School of Medicine, Isehara, Kanagawa 259-1193, Japan. kuematsu@saitama-med.ac.jp
13. Targeting the Wnt signaling pathway with dishevelled and cisplatin synergistically suppresses mesothelioma cell growth. Year Published: 2008
Division of Clinical Oncology, Tokai University School of Medicine, Isehara, Kanagawa 259-1193, Japan. kuematsu@saitama-med.ac.jp